However, these benefits are taken against the risks of chemothera

However, these benefits are taken against the risks of chemotherapy induced parenchymal damage including steatosis, steatohepatitis, and sinusoidal obstruction (SOS). Steatosis (fatty liver disease) is most recognized in alcoholic hepatitis and nonalcoholic fatty liver disease (NAFLD). This pathology is represented macroscopically as a yellow liver, and histologically Inhibitors,research,lifescience,medical by retained lipid in micro and macrovesicles, altering the normal architecture of hepatocytes and their associated function (62). Steatohepatitis represents progression of steatosis, presumably from oxidative stress

which causes lipid peroxidation and the development of necrotizing inflammation and unregulated hepatocellular apoptosis (63-65). Sinusoidal obstruction syndrome (SOS) represents the endpoint of progression of chemotherapy toxicity. Microscopically this condition is represented by edema of central zone hepatocytes and fibrosis and

congestion of the sinusoids (66-68). 5-Fluorouracil (5-FU) alone has been reported to induce steatosis Inhibitors,research,lifescience,medical in 40-47% of patients (69-71). Addition of the platinum based agents like oxaliplatin or the topoisomerase inhibitor irinotecan has also shown to have hepatic toxicity with oxaliplatin being independently Inhibitors,research,lifescience,medical associated with steatohepatitis and irinotecan with SOS (65). The addition of the anti-VEGF antibody bevacizumab Inhibitors,research,lifescience,medical has increasing adoption as a chemotherapeutic and it is found to have a protective effect against oxaliplatin induced SOS (72). Taking into account neoadjuvant chemotherapy toxicities, multiple groups have examined perioperative outcomes as they relate to steatosis, steatohepatitis, and SOS (Table 2). Patients with steatosis after chemotherapy and Inhibitors,research,lifescience,medical eventual hepatectomy are predisposed to increased post-operative complications, but without increased Sirtuin pathway mortality

(75-77). For patients with steatohepatitis, there is a more significant effect on post operative liver function and patient survival following resection (65). Fewer studies have directly examined SOS as a perioperative risk factor, but as described earlier, the venous congestion in this condition predisposes to risk of transfusion, and likely the detrimental effects of transfusions are Chlormezanone consequently involved (78). Table 2 Demonstration of hepatic parenchymal injury after chemotherapy for metastatic colorectal cancer. While many groups have examined these histopathologies as they relate to perioperative outcomes, there is little consensus on the time interval between neoadjuvant therapy and hepatectomy and duration of chemotherapy. Welsh et al. showed that patients with a history of neoadjuvant chemotherapy had increased post-operative complications, with a duration of greater than five weeks protecting against complications (79). Karoui et al.

3 hours longer than those who had never been depressed Though su

3 hours longer than those who had never been depressed. Though such a finding should be interpreted as very preliminary, it does give us greater confidence in the primary finding of the study, that depression is associated with longer ED LOS. It also suggests that there may be a more

general depressive presentation, as evinced by a history of depression, that may influence patients’ ED experience. Possible explanations for our findings are that depression may influence how ACS patients present in the ED, their reporting of symptoms, their ability to recruit a family member or friend to accompany and support them, or their interactions with medical staff. At this stage, Inhibitors,research,lifescience,medical however, such explanations are speculation, as more research must be conducted. While previous research has shown that posttraumatic stress disorder is associated with longer patient delay to ED presentation in this sample of ACS patients, this is the first study to report an association between depression and Inhibitors,research,lifescience,medical ED LOS [4]. We do not yet know why depressed ACS patients are at risk for poor medical outcomes, but Inhibitors,research,lifescience,medical delay

to medical inpatient services may be one possible factor, of many, contributing to their poor prognosis. While we found that only depression and time of presentation were associated with individual participants’ LOS, characteristics of each individual and of the specific ED we studied likely influenced our outcome measure. While such influences are obviously multifactorial,

they include severity of presenting illness, availability of floor beds, and availability of “spots” on accepting services. Though there may be some variability due to the presence or absence of a private cardiologist or certain clinical conditions, Inhibitors,research,lifescience,medical systemic delays in the admission process for patients eligible for inclusion in the parent study (PULSE) are largely administrative in nature and relate to lack of bed capacity or the availability of medical teams. In general, ACS patients are Inhibitors,research,lifescience,medical admitted to the Chest Pain Nurse Practitioner service during daytime hours or otherwise to the hospitalist service. Those admitted to cardiology have generally been ruled in for NSTEMI during their stay in the ED or are otherwise complicated. ACS patients are not generally admitted to the CCU unless Liothyronine Sodium they qualify for percutaneous LY317615 coronary intervention (PCI) or are clinically unstable. ACS patients may occasionally be admitted to resident teams other than cardiology. Our knowledge of the admission process, including that through which ACS patients are parsed to floors and provider teams, has not led to a hypothesis that can account for our finding that depressed patients have longer ED LOS. Limitations This study must be interpreted with its limitations in mind. First, these data represent findings from a single, large, urban academic medical center, and as such, the external validity may be limited.

It was proposed that local spread of inflammation of

It was proposed that local spread of inflammation of transverse colon to biliary organs like gallbladder

resulting in an acute inflammatory process which subsequently resulted in an acute acalculous cholecystitis mimicking gall bladder carcinoma. Conclusions We present an interesting case of colon cancer colon that caused diagnostic confusion by mimicking as carcinoma gall bladder. Colorectal cancer constitutes a major public health issue globally. Lack of awareness of the disease, lack of diagnostic facilities, lack of screening programs, poor accessibility to healthcare facilities and adjuvant therapy, Inhibitors,research,lifescience,medical the high cost of care, high morbidity and mortality are among the trademarks of the disease lead to its great challenge in the management of these patients. Therefore, public awareness, screening of high-risk populations, early diagnosis and effective

cost-effective Inhibitors,research,lifescience,medical treatment and follow-up will help to reduce its occurance and further complications. Acknowledgements Disclosure: The authors declare no conflict of interest.
Esophageal cancer is the eighth most common cancer worldwide and the sixth cause of cancer related death (1-3). Squamous cell carcinoma (SCC) is the leading pathological type with mean rates of incidence of 2.5-5/100.000 cases among men and 1.5-2.5 cases among women but higher incidence rates are reported in high risk Inhibitors,research,lifescience,medical countries such as China, Iran, South Africa and France (4,5). Principal risk factors for its development are alcohol consumption, smoking, nutritional deficiencies and physical injuries but several studies Inhibitors,research,lifescience,medical have evaluated the possible association with infections (6). The role of human papilloma virus (HPV) has been investigated with controversial results. Persistent HPV infection has been detected in benign esophageal squamous cells tumors (4) but there are no studies

proving a clear causal association between HPV infection and cancer. Since 1982 at least 70 studies have reported detection rates of HPV in esophageal SCC ranging from 0% to 67% (7) with Inhibitors,research,lifescience,medical viral type 16 being the most common (8,9). Given the lack of evidence Sclareol regarding the significance of HPV in esophageal SCC, no specific indications or guidelines for possible endoscopic and surgical therapeutic approaches to this clinical SB202190 scenario are available. European Organization for Research and Treatment of Cancer (EORTC) treatments strategies for esophageal SCC suggest the use of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) in early cancers with exclusive mucosal involvement with more aggressive surgical approaches indicated in those cases in which submucosal invasion is present (10). Radiofrequency ablation (RFA) is an endoscopic technique that is currently used for the treatment of flat high-grade dysplasia in Barrett’s esophagus (11).

One drawback of the novel refreshers is that they may be treated

One drawback of the novel refreshers is that they may be treated as SPAM by recipients, given the large numbers of electronic contacts that individuals typically receive. Also, there is a natural tendency to ignore information that is not immediately salient, as when there is no immediate need to perform CPR. In that respect the modest, “low tech” CPR reminder card may be a superior device – the subject carries it in their purse or wallet and can refer to it when and if the occasion for performing

CPR arises. The four refreshers utilized in this study do not enable immediate access to information Inhibitors,research,lifescience,medical at the precise time it’s needed. Study limitations The relatively high attrition rate of subjects for follow-up testing may have contributed to a reduction in the power of the statistical tests Inhibitors,research,lifescience,medical for http://www.selleckchem.com/products/Everolimus(RAD001).html refresher effects. Many of the subjects, particularly the students, were difficult to re-contact, and the study’s resources were not sufficient for intensive, repeated follow-up efforts. The study was limited in being able to document the degree of actual exposure to Inhibitors,research,lifescience,medical the refreshers. Originally, data were collected on the number of e-mails and pdf files opened by the e-mail group, the number of text messages responded to by the text message group, and

the number of website “nodes” visited by the

website group. However, the recording of the “node information” made detailed Inhibitors,research,lifescience,medical exposure analysis unfeasible, and as such, the exposure variables for all novel refresher groups were restricted to a dichotomous indicator (no exposure vs. some exposure). On balance, inspection of the partial data on refresher exposure available indicates that most subjects did not review most of the electronic refresher material sent. Thus, it is possible that the novel refresher approach could be more effective if subjects could be encouraged to review more of the material when it is sent to them. Directions for future research Inhibitors,research,lifescience,medical Additional research on novel electronic refreshers seems justifiable, given our finding that novel refreshers may affect prior trainees’ confidence in performing CPR and that exposure to an online website refresher appeared to affect intent to perform CPR. Further first research with a website refresher may be most promising, because this allows for greatest interactivity with the subject and would provide excellent access due to internet availability on smartphones, a technology that was still rare when the current study was designed. The finding that age, educational level and ethnicity were related to retention of CPR skills could lead to further research investigating the reason(s) for these relationships.

Happy mood participants will demonstrate mood-congruence and cro

Happy mood participants will demonstrate mood-congruence and cross-modality indexed by longer response latencies for positive stimuli (positive words/happy faces). Method Participants One-hundred

and twenty-four undergraduate females signed up for the experiment in exchange for study credit. Eight participants were excluded for nonfluency in Dutch, leaving the final Inhibitors,research,lifescience,medical sample of 116 female university students with a mean age of 20.9 (SD = 2.9) years. Participation was restricted to females to control for potential gender influences and Dutch fluency to control for potential confounds on the verbal-emotional Stroop task. All study participants were further Inhibitors,research,lifescience,medical screened for current and past mood complaints, cognitive impairments, color vision, and dyslexia. Materials Questionnaires All participants completed the Dutch versions of the State-Trait Anxiety Inventory (STAI) (Van der ploeg et al. 1980), Positive Affect and Negative Affect Scale (Peeters et al. 1996), and finally the Beck Depression Inventory (BDI) (Bouman et al. 1985). Mood induction films and mood rating scale Mood induction movie clips consisted of Happy Feet for the positive mood and Sophie’s

Choice for the sad mood. These specific film segments have been validated and proven to be reliable Inhibitors,research,lifescience,medical in previous studies (Fitzgerald et al. 2011) Inhibitors,research,lifescience,medical and in general, movie segments are considered a highly reliable technique for inducing mood (Westermann et al. 1996). Both the sad and happy mood induction consisted of a 12-min clip and

a 7-min clip given at two separate time intervals. Participants were instructed to identify with the protagonist in the movie and “get into the same mood.” Mood ratings were collected using a computerized visual analogue scale that ranged from −10 (indicating saddest mood) to 10 (indicating happiest mood). Color and Inhibitors,research,lifescience,medical verbal-emotional Stroop A modified computerized Stroop color-naming task with emotional as well as color words was used. The Stroop consisted of five blocks of three trials each: sad words, happy words, fearful words, neutral words, and color words. A practice trial, containing 15 words selected from the different blocks, preceded the testing phase. The valenced words (from Rutecarpine a Dutch translation of the Affective Norms for English Words database, Bradley and Lang 1999) were matched for length, frequency, and learn more valence strength (see Table 1). The color trials contained the words “red,”“yellow,”“green,” and “blue.” The color block was always presented last, while the order of the other blocks was randomized across participants. The trials contained 48 words each and were sorted in four different columns. Within a block, the words were presented in a different order.

Neuroprotection Considerable interest has been shown in putative

Neuroprotection Considerable interest has been shown in putative neuroprotective actions of lithium, particularly with regards to dementing illnesses, although the epidemiological evidence remains challengeable [Young, 2011]. Several of the previously described mechanisms, independently or synergistically, may be protective of brain cell functioning [Chiu and Chuang 2010]: inhibition of glutamatergic excitotoxicity via NMDA receptor-mediated calcium influx; inhibition of autophagy, including in the presence of the insult of β-amyloid [Alvarez et al. 2002]; increasing neuronal growth cones, via IMPase inhibition and inositol depletion; and induction and upregulation

of the cortical developmental neurotrophins Inhibitors,research,lifescience,medical brain-derived neurotrophic factor (BDNF) [Yasuda et al. 2009] and vascular endothelial growth factor (VEGF) [Guo et al. 2009]. Grey and white matter volume Magnetic resonance imaging

Inhibitors,research,lifescience,medical (MRI) studies have demonstrated increased grey matter volume in bipolar patients, following administration of lithium [Moore et al. 2000b; Sassi et al. 2002; Bearden et al. 2007]. Studies have generally failed to identify any effects in white matter, although Monkul and colleagues found increased dorsolateral prefrontal cortex and cingulate grey matter volume and increased white matter volume in healthy subjects Inhibitors,research,lifescience,medical following lithium administration [Monkul et al. 2007], potentially highlighting the different generalised effects of lithium in healthy and diseased brains. The regional specificity of these findings makes it unlikely

that these findings are due to the osmotic effects of lithium; instead, Inhibitors,research,lifescience,medical the neurotrophic effect of lithium seems a more viable explanation [Moore et al. 2000b; Sassi et al. 2002; Bearden et al. 2007; Monkul et al. 2007]. Notably, lithium’s ability to Inhibitors,research,lifescience,medical robustly increase expression of the cytoprotective protein B-cell lymphoma/leukaemia 2 (bcl-2) [Chen et al. 1999; Manji et al. 2000a; Moore et al. 2000b], as well as its effects on GSK3 [Klein and Melton, PDK4 1996; Stambolic et al. 1996; Chalecka-Franaszek and Chuang, 1999; De Sarno et al. 2002; Beaulieu et al. 2004], is thought to exert major neurotrophic effects, resulting in neuropil increases, increased N-acetyl-aspartate (NAA) levels (a postulated marker of neuronal viability and function), with significant effects on grey matter volume [Manji et al. 2000b; Moore et al. 2000a]. Conclusion: pulling the evidence together Lithium is chemically remarkably simple and, in human neuronal tissue, biochemically remarkably AP24534 in vitro complex. Its clinical efficacy in mood disorders is well established and there is growing epidemiological evidence to support broader effects including positively altering aggression and suicide rates, and potentially being protective against neurodegenerative disorders.

A summary about the most important features of the discussed soft

A summary about the most important features of the discussed software packages is given in Table 1. Table 1 Overview about various lipidomic data processing software packages. Developed by AB Sciex, Lipid View is the only commercially available lipidomic processing software so far. The concept of this software is based on the earlier developments of Lipid Profiler [24] and Lipid Inspector [23]. Basically all three software packages rely on shotgun data EPZ5676 mouse acquired by MPIS either on low resolution or high resolution instrumentation. Inhibitors,research,lifescience,medical The software processes information about precursor

and fragment masses obtained from full scan and MS/MS data and matches it against an internal database containing possible fragments for molecular lipid species. On the downside, Lipid View is only able to process data acquired on AB Sciex triple quadrupole or quadrupole-TOF instruments, which severely limits the software’s availability to the lipid mass spectrometry community. Recently, the group of Shevchenko has launched LipidXplorer,

Inhibitors,research,lifescience,medical an informatics concept based on molecular fragmentation query language (MFQL) [75]. LipidXplorer is designed for shotgun lipidomics and takes MS full scan data and product ion scans into account. Although Inhibitors,research,lifescience,medical it is also possible to process low resolution data, this program is primarily developed Inhibitors,research,lifescience,medical for high resolution spectra and was shown to work best with LTQ-Orbitrap or quadrupole-TOF instrumentation. In contrast to other shotgun lipidomics software packages, LipidXplorer does not rely on a database for MS/MS spectra but rather depends on the concept of fragmentation queries, which reflects the variability of MS/MS spectra due to different

experimental settings much better. The software allows a lot of freedom for the user, like, for example, customized adjustment to various experimental parameters, but this requires some dedication. Processing of LC-MS generated data is usually more challenging because retention time adds Inhibitors,research,lifescience,medical another dimension of information. Endonuclease Originally developed for metabolomic data acquired by mass spectrometry [76,77], m/zMine and its sequel m/zMine2 were also successfully applied on lipidomic data [78]. Following peak detection, identification of lipids is performed by searches in public libraries or customized internal databases containing exact mass and approximate retention times. Furthermore also isotopic distributions and adducts can be taken into account for lipid identification. Although originally applied on quadrupole-TOF LC-MS data, m/zMine2 has become a versatile and highly flexible software, which can be used for data generated with various experimental platforms. In contrast to other software solutions, Lipid Data Analyzer (LDA) is based on a 3D algorithm (m/z, retention time, intensity) for peak detection [79].

e the strongest association between the drug and an adverse even

e. the strongest association between the drug and an adverse event) for pituitary tumors followed by haloperidol, ziprasidone and olanzapine. The incidence of reports of hyperprolactinaemia

and galactorrhoea were also higher with risperidone than with other antipsychotics. In the literature, hyperprolactinemia, one of the endocrinological side effects due to Selleck P450 inhibitor antipsychotics, has been frequently observed; however, pituitary macroadenoma has not been reported. Pituitary adenomas constitute 10–20% of all intracranial neoplasm [Erer et al. 2008]. The development of pituitary Inhibitors,research,lifescience,medical adenoma is considered to be multifactorial. It is thought that a somatic point mutation arises initially in one cell and the event progresses with secondary mutations. Environmental factors, growth factors, hormones and changes in receptors influence the behavior of biological changes in tumors Inhibitors,research,lifescience,medical [Shahlaie

et al. 2010]. Pituitary adenomas result in significant morbidity due to local pressure effects and hormone hypersecretions. Treatment requires the work of a team of brain surgeons, endocrinologists and radiation oncologists [Debono and Newell-Price, 2010]. The most common Inhibitors,research,lifescience,medical cause of acromegaly is pituitary adenomas synthesizing GH and it is a known risk factor for cardiovascular mortality. When GH secretion cannot be controlled in these patients, the metabolic changes result in mortality and/or morbidity. Compared with the general population, acromegalic patients have 2.4- to 4.8-fold increased mortality rate [Holdaway et al. 2004; Kauppinen-Makelin Inhibitors,research,lifescience,medical et al. 2005]. Elevated prolactin levels are seen in ~30% of patients [Komossa et al. 2011]. Although studies cannot establish the absence or presence of a causal relationship between second-generation antipsychotic agents treatment generally (and risperidone treatment specifically), and pituitary adenomas, it is important to recognize that pituitary adenomas of clinical relevance may still occur in Inhibitors,research,lifescience,medical patients receiving antipsychotic medication, and that patients with symptoms suggesting

pituitary adenomas should receive full appropriate evaluation. As with other second-generation antipsychotics, endocrinological side effects were identified and pituitary macroadenoma cases increasing with growth hormone due to risperidone treatment have been reported for the first time, which Thiamine-diphosphate kinase gives importance to our case study. According to Gianfrancesco and colleagues (as reported in the pharmacovigilance study by Szarfman et al. [2006]), compared with other antipsychotics, risperidone-treated patients were found to have a higher risk of the occurrence of pituitary tumors [Gianfrancesco et al. 2009]. This suggests that, when a high level of prolactin is detected in patients treated with risperidone, it is worth doing pituitary tumor research using brain imaging studies, because these tumors are usually small, benign and remain endocrinologically silent [Lopes, 2010].

9%) affective disorders, and 12 of 61

(19 6%) other psych

9%) affective disorders, and 12 of 61

(19.6%) other psychotic disorders. The R-PTSD inventory facilitated diagnosis of comorbid PTSD in 91.8% of patients (56 of 61). As previously shown, the inventory correlated well with the Schizophrenia Clinical Interview for Diagnosis (SCID). Thus, comorbid PTSD can be said to be reliably diagnosed in the overwhelming majority of subjects in the present study. Inhibitors,research,lifescience,medical The IES results demonstrated a significant difference between intrusive and avoidance symptoms. While both subscales were scored as significantly Selleck ZD1839 higher than the reported means for the normal population, intrusions were scored as notably more prominent than avoidance. Mean intrusion score was 42.7 ±4.1 (range Inhibitors,research,lifescience,medical 3651) and mean avoidance score was 29.7±3.4 (range 2731); < 0.01 [paired Student /-test]). The IES scores in the present study are in the range of a previous study of elderly subjects suffering from PTSD reported by our group.33 Discussion Our sample represents a unique group of elderly Holocaust survivors who show a high comorbidity of chronic PTSD (91.8%), Inhibitors,research,lifescience,medical with psychotic disorders more than 50 years after the experience of the massive psychic trauma of the Holocaust. The occurrence of chronic PTSD of such magnitude for an extremely prolonged period is striking. It is significantly higher than the rate

reported for war veterans, ranging from 12.4%14 to 45%. 13 This difference may be related to Inhibitors,research,lifescience,medical the unique nature of the Holocaust trauma, combining dehumanization, confrontation with death, and massive loss for a prolonged period.21 Beal15 demonstrated that the co-occurrence of imprisonment in addition to the experience of combat led to a higher incidence of PTSD and other psychological symptoms, compared to combat experience alone. Furthermore, Kidson ct al13 show that the specific nature

of the Inhibitors,research,lifescience,medical traumatic experience, such as taking of casualties, or the experience of combat stress, resulted in more pronounced severity, and was significantly associated with the occurrence of PTSD in WWII veterans. Thus, the specific nature of the traumatic experience may influence the occurrence of PTSD and its persistence over time. Beyond this aspect, MTMR9 the coexistence of a severe psychotic disorder in our scries of patients seems to bc decisive. As demonstrated by Kidson et al,13 even minor pathologies, such as anxiety and depressive disorders, were more common in war veterans with PTSD. Therefore, this seems to suggest that the severity of the coexistent psychiatric morbidity, such as schizophrenia, may explain the high incidence of chronic PTSD present for such a prolonged period. It is difficult to say whether the occurrence of PTSD in our group represents lifelong suffering, beginning close to the end of the traumatic experience and persisting for more than 50 years, or whether it represents a phase of symptomatic reactivation occurring in WWII veterans in their old age, as demonstrated by Macleod.

2013) Furthermore, JDTic-induced suppression of spontaneous reco

2013). Furthermore, JDTic-induced suppression of spontaneous recovery of alcohol responding can occur up to 14 days after JDTic treatment (Deehan et al. 2012). The reasons for these discrepancies in the time course of the antagonism of KOR and the suppressive actions of nor-BNI and JDTic on drug- or alcohol-related behaviors are not clear. One potential explanation is that at the 2 h post nor-BNI injection time point we use, the early-appearing MOR antagonist Inhibitors,research,lifescience,medical properties of nor-BNI may be

still present (Endoh et al. 1992). This is unlikely to be the case, as the MOR blockade induced by nor-BNI occurs in the first hour after administration. Inhibitors,research,lifescience,medical By 2 h post injection, selectivity for KOR is 100-fold higher than for MOR (Endoh et al. 1992). Furthermore, we saw a complete blockade by nor-BNI of the reinstatement induced

by the highly selective KOR agonist U50,488 at 2, but not 24 h. Another possibility is that time-dependent effects are highly specific to the outcomes measured. For example, most of the data on the long-lasting effects of nor-BNI come from BIIB057 studies measuring pain, which is mediated by quite different systems than are motivated behaviors. Arguing against this idea, however, are recent findings Inhibitors,research,lifescience,medical that nor-BNI blocked yohimbine-induced reinstatement of heroin seeking 24 h after administration (Zhou et al. 2013), and our observation that nor-BNI was still able to significantly attenuate yohimbine-induced reinstatement of nicotine seeking 24 h after administration (Grella, Funk, Coen, Li, Lê, in revision). KOR and stress-induced Inhibitors,research,lifescience,medical alcohol seeking The selective KOR antagonist, nor-BNI significantly attenuated reinstatement of alcohol

seeking induced by the pharmacological stressor yohimbine. These results a support those from studies on the role of KOR and stress in the expression of CPP to other drugs. Nor- BNI blocks stress- and U50,488-induced potentiation of CPP to cocaine (Schindler et al. 2010) or alcohol (Sperling et al. 2010) as Inhibitors,research,lifescience,medical well as stress-induced reinstatement of lever second pressing for cocaine (Beardsley et al. 2005), heroin (Zhou et al. 2013) or nicotine (Grella, Funk, Coen, Li, Lê, in revision) in rats. Taken together, these and our present data support the idea that KOR plays an important role in stress-induced drug seeking. However, one study reported that KOR blockade with JDTic did not affect footshock-induced reinstatement (Schank et al. 2012). The reasons for the discrepant findings are not clear. It is unlikely that nonspecific effects of nor-BNI produced the reduction in yohimbine-induced reinstatement we observed, as Schank et al. (2012) found that a dose of nor-BNI three times higher than what we used did not affect operant responding for sucrose.